NDC 71335-1200

Gabapentin

Gabapentin

Gabapentin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Gabapentin.

Product ID71335-1200_00d46097-f257-4512-89f2-0e035136aae1
NDC71335-1200
Product TypeHuman Prescription Drug
Proprietary NameGabapentin
Generic NameGabapentin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA206402
Labeler NameBryant Ranch Prepack
Substance NameGABAPENTIN
Active Ingredient Strength600 mg/1
Pharm ClassesAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71335-1200-0

28 TABLET in 1 BOTTLE (71335-1200-0)
Marketing Start Date2022-09-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1200-4 [71335120004]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

NDC 71335-1200-1 [71335120001]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

NDC 71335-1200-0 [71335120000]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

NDC 71335-1200-7 [71335120007]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

NDC 71335-1200-9 [71335120009]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

NDC 71335-1200-2 [71335120002]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

NDC 71335-1200-6 [71335120006]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

NDC 71335-1200-3 [71335120003]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

NDC 71335-1200-8 [71335120008]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

NDC 71335-1200-5 [71335120005]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA206402
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-26
Marketing End Date2020-04-30

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN600 mg/1

OpenFDA Data

SPL SET ID:a1ff94a9-69c4-486a-aab2-563c7ed244c8
Manufacturer
UNII

Pharmacological Class

  • Anti-epileptic Agent [EPC]
  • Decreased Central Nervous System Disorganized Electrical Activity [PE]
  • Anti-epileptic Agent [EPC]
  • Decreased Central Nervous System Disorganized Electrical Activity [PE]

NDC Crossover Matching brand name "Gabapentin" or generic name "Gabapentin"

NDCBrand NameGeneric Name
0093-4443GabapentinGabapentin
0093-4444GabapentinGabapentin
0143-3991GabapentinGabapentin
0143-3993GabapentinGabapentin
0143-3994GabapentinGabapentin
0143-9992GabapentinGabapentin
0143-9993GabapentinGabapentin
0143-9994GabapentinGabapentin
67877-222GabapentinGabapentin
67877-223GabapentinGabapentin
67877-224GabapentinGabapentin
67877-428GabapentinGabapentin
67877-429GabapentinGabapentin
68001-006GabapentinGabapentin
68001-007GabapentinGabapentin
68071-1212GABAPENTINGABAPENTIN
68071-1292GabapentinGabapentin
68071-1808GABAPENTINGABAPENTIN
68071-1907GABAPENTINGABAPENTIN
68071-1995GabapentinGabapentin
68071-3230GABAPENTINGABAPENTIN
68071-3046GabapentinGabapentin
68071-3244GabapentinGabapentin
68071-4087GabapentinGabapentin
68071-3086GABAPENTINGABAPENTIN
68071-3383GABAPENTINGABAPENTIN
68071-3314GABAPENTINGABAPENTIN
68071-4049GABAPENTINGABAPENTIN
68071-4241GABAPENTINGABAPENTIN
68071-4099GabapentinGabapentin
68071-4113GabapentinGabapentin
68071-4292GabapentinGabapentin
68071-4180GabapentinGabapentin
68071-4090GabapentinGabapentin
68071-4329GabapentinGabapentin
68071-4603GabapentinGabapentin
68071-4169GabapentinGabapentin
68071-4346GabapentinGabapentin
68071-4366GabapentinGabapentin
68071-4729GabapentinGabapentin
68071-4402GABAPENTINGABAPENTIN
68071-4784GABAPENTINGABAPENTIN
68084-774GabapentinGabapentin
68084-783GabapentinGabapentin
68084-797GabapentinGabapentin
68084-762GabapentinGabapentin
0440-5562GABAPENTINGABAPENTIN
0440-5563GABAPENTINGABAPENTIN
68084-802GabapentinGabapentin
68151-1028GabapentinGabapentin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.